Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Sell
2,200
-9,800
-82% -$894K 0.15% 56
2026
Q1
$1.23M Buy
+12,000
New +$1.35M 0.78% 38
2024
Q4
Sell
-20,000
Closed -$2.28M 185
2024
Q3
$2.28M Buy
+20,000
New +$2.19M 1.54% 28

Other funds holding ABT

Syntax Research's ABT Position: Q2 2026 in Review

Syntax Research reduced its Abbott (ABT) stake by 82% in Q2 2026, selling an estimated $894K and leaving 2,200 shares worth $200K. The position accounts for 0.15% of the portfolio, ranked #56.

Syntax Research first reported a position in ABT in Q3 2024 and has held it in 3 quarters since. The position peaked at $2.28M in Q3 2024. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Syntax Research held 2,200 shares of Abbott worth $200K as of Q2 2026.
  • Syntax Research sold 9,800 Abbott shares in Q2 2026, an estimated $894K.
  • Abbott made up 0.15% of Syntax Research's portfolio in Q2 2026, its #56 holding.
  • Syntax Research first reported a position in Abbott in Q3 2024 and has held it in 3 quarters since.
  • Syntax Research's Abbott position peaked at $2.28M in Q3 2024.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.